| Biotechnology Industry | Healthcare Sector | Mr. Chia-De Lai CEO | TWSE Exchange | TW0004155007 ISIN |
| TW Country | - Employees | 4 Jul 2025 Last Dividend | 22 Jun 2020 Last Split | - IPO Date |
OK Biotech Co., Ltd., established in 2006, is a pioneering manufacturer and international distributor of blood glucose monitoring devices and a range of homecare medical products. The company has its headquarters in Hsinchu City, Taiwan, echoing its commitment to excellence in healthcare innovation and accessibility. It strives to provide high-quality healthcare solutions worldwide, aiming to enhance the daily lives of individuals needing medical care at home.
OK Biotech Co., Ltd. specializes in the development and distribution of advanced blood glucose monitoring systems. These devices are designed for people with diabetes or those needing to track their blood sugar levels for health reasons. The company's focus on accuracy and user-friendliness makes these devices a critical tool in personal health management.
A cornerstone of OK Biotech's product line is its glucometers and corresponding blood glucose test strips, which work hand in hand to provide accurate blood sugar readings. These products are tailored for easy use at home, enabling patients to monitor their conditions effectively without frequent visits to healthcare facilities.
In addition to blood glucose monitoring, OK Biotech offers a variety of nebulizing devices, including standard, portable, and mesh nebulizers. These are designed to deliver medication directly to the lungs in aerosol form for patients with respiratory conditions, such as asthma or COPD, enhancing medication efficacy and patient comfort.
Expanding its range of healthcare products, OK Biotech also provides personal sound amplifiers. These devices are crafted for individuals with hearing impairments, allowing them to engage in conversations and enjoy daily activities with improved sound clarity, thereby improving their quality of life.